Skip to content

nGEN Generator D138402

by Biosense Webster Inc

Active European Union and United States. Also listed in GUDID (US).

CE MDR PMA

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

1 ongoing

This device is named in the recall

Documents

None linked in EUDAMED

A group certificate may exist

PMA P040036

+5 more

Trust

Unverified

Source EUDAMED, GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing GUDID Number10846835018080 UDI-DI Date18 Aug 2022ListedStatusListed GUDID: in commercial distribution
United StatesFDA PMAAPPR GUDID from GUDID Approved NumberP040036 Date11 Aug 2006DecidedStatusActive
European UnionCE/MDR EUDAMED Number— Date—StatusActive

Official records

Across registries

3 registries list this device

  • FDA PMA P040036 decided 11 Aug 2006 Active· +5 more in the status table
  • EUDAMED Active
  • FDA GUDID UDI-DI 10846835018080 listed 18 Aug 2022 Listed

Recalls

12 recalls · 1 ongoing · FDA

    • Ongoing Z-0169-2023 FDA Class II initiated 7 Sep 2022

    Manufacturing error resulted in potential contamination of Bi-Directional navigation catheter irrigation path with cellulose fibers that can cause 1) Failure of initial flushing inspection, 2) Insufficient irrigation causing catheter tip temperature increase, limiting the ability to deliver ablation, or 3) particles flushed through the catheter irrigation may have thrombogenic/toxic effect.

    • Terminated Z-0058-2018 FDA Class II initiated 6 Sep 2017

    Biosense Webster, Inc. has recently received an increased number of complaints related to the display of Alert 402 on the CARTO 3 System for certain lots of THERMOCOOL brand catheters. Alert 402 implies a "Map: magnetic distortion" when connected to CARTO 3 System. This issue may subsequently lead the physician to ablate in an unintended area when delivering RF energy.

    • Terminated Z-0139-2015 FDA Class II initiated 19 Oct 2014

    The recall was initiated because Biosense Webster is providing additional labeling for the safe and effective use of the ThermoCool SmartTouch Catheter.

    • Terminated Z-3178-2011 FDA Unclassified (pre-2012) initiated 7 Jul 2011

    Biosense Webster has initiated a voluntary field notification to all customers that have a Stockert 70 Radio Frequency Generator, to communicate undetected software anomalies in the form of software release note in order to amend the labeling and thereby enhance the safety of the product.

  • 5 recalls, same reason

    • Terminated Z-0982-2012 FDA Unclassified (pre-2012) initiated 22 Nov 2010
    • Terminated Z-0981-2012 FDA Unclassified (pre-2012) initiated 22 Nov 2010
    • Terminated Z-0979-2012 FDA Unclassified (pre-2012) initiated 22 Nov 2010
    • Terminated Z-0983-2012 FDA Unclassified (pre-2012) initiated 22 Nov 2010
    • Terminated Z-0980-2012 FDA Unclassified (pre-2012) initiated 22 Nov 2010

    Biosense Webster, Inc. has recently become aware of the omission of the following two Warning and Precaution statements on the Instructions For Use (IFU) for the above catheter: 1. If phrenic nerve location is a concern, precautionary measures are recommended to evaluate the proximity of the nerve to the ablation electrode, such as pacing maneuvers. 2. To minimize risk of atrio-esophageal fist

    • Terminated Z-0369-2010 FDA Unclassified (pre-2012) initiated 2 Oct 2008

    Biosense Webster initiated the recall because of the potential concern with one of the Printed Circuit Board (PCB) components used in the NaviStar RMT Catheters, which may cause the ablation catheter icon to shift on the map viewer when RF energy is being applied. Therefore the user, attempting a linear ablation in the location displayed on the CARTO RMT screen, may ultimately apply RF energy to u

    • Terminated Z-0057-06 FDA Unclassified (pre-2012) initiated 8 Aug 2005

    Increased complaints regarding catheters with leaks and flow obstruction.

    • Terminated Z-1328-04 FDA Unclassified (pre-2012) initiated 16 Jul 2004

    Generator Failure resulting increase of catheter temperature that could not be controlled by power reduction.

Timeline

19 dated events

  1. Recall initiated FDA recalls Z-0982-2012
  2. Recall initiated FDA recalls Z-0981-2012
  3. Recall initiated FDA recalls Z-0979-2012
  4. Recall initiated FDA recalls Z-0983-2012
  5. Recall initiated FDA recalls Z-0980-2012
  6. Recall initiated FDA recalls Z-3178-2011
  7. Recall initiated FDA recalls Z-0139-2015
  8. Recall initiated FDA recalls Z-0058-2018
  9. Listed FDA GUDID 10846835018080
  10. Recall initiated FDA recalls Z-0169-2023

9 earlier events are in the sections above.

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States FDA PMA Active

Specification

EUDAMED · GUDID

Trade name
nGEN Generator
Generic name
Cardiac radio-frequency ablation system generator
Model / Ref / Catalog
D138402
Primary DI / UDI-DI
10846835018080
FDA product code
LPB, OAE, DRF, OAD
GMDN term
Cardiac radio-frequency ablation system generator
Device class
Class III
Regulation number
870.1220
GUDID distribution status
In Commercial Distribution

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The nGEN Generator D138402 is a cardiac radio-frequency ablation system generator, designed to generate radio-frequency energy for creating ablative lesions in cardiac tissue during arrhythmia treatment. It includes control interfaces and may integrate with electrocardiograph (ECG) monitoring, supporting both endocardial ablation via percutaneous catheters and epicardial ablation with electrode probes.

This reusable, non-sterile device is intended for use in clinical settings requiring prescription authorization and is classified under EU MDR. It requires special storage conditions, including protection from moisture and direct sunlight, and is supplied with a single-unit package. The device lacks an expiration date but includes manufacturing and serial number markings for traceability. MRI safety information is not provided for this model.

Similar devices

Other devices filed under FDA product code LPB (Cardiac ablation percutaneous catheter).

Other devices from Biosense Webster Inc

See all devices from Biosense Webster Inc →

Properties

  • Prescription use
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)